These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27330257)

  • 41. Otoacoustic emission screen results in critically ill neonates who received gentamicin in the first week of life.
    Cooper AC; Commers AR; Finkelstein M; Lipnik PG; Tollefson LM; Wilcox RA; Hoff DS
    Pharmacotherapy; 2011 Jul; 31(7):649-57. PubMed ID: 21923451
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of two gentamicin dosing schedules in very low birth weight infants.
    Rastogi A; Agarwal G; Pyati S; Pildes RS
    Pediatr Infect Dis J; 2002 Mar; 21(3):234-40. PubMed ID: 12005088
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant Tuberculosis.
    van Altena R; Dijkstra JA; van der Meer ME; Borjas Howard JF; Kosterink JG; van Soolingen D; van der Werf TS; Alffenaar JW
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069654
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Challenges in comparing treatment outcome from a prospective with that of a retrospective study: assessing the merit of gentamicin therapeutic drug monitoring in pediatric oncology.
    Ho KK; Thiessen JJ; Bryson SM; Greenberg ML; Einarson TR; Leson CL
    Ther Drug Monit; 1994 Jun; 16(3):238-47. PubMed ID: 8085278
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Population pharmacokinetics/pharmacodynamics of micafungin against Candida species in obese, critically ill, and morbidly obese critically ill patients.
    Maseda E; Grau S; Luque S; Castillo-Mafla MP; Suárez-de-la-Rica A; Montero-Feijoo A; Salgado P; Gimenez MJ; García-Bernedo CA; Gilsanz F; Roberts JA
    Crit Care; 2018 Apr; 22(1):94. PubMed ID: 29655372
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma Peak and Trough Gentamicin Concentrations in Hospitalized Horses Receiving Intravenously Administered Gentamicin.
    Bauquier JR; Boston RC; Sweeney RW; Wilkins PA; Nolen-Walston RD
    J Vet Intern Med; 2015; 29(6):1660-6. PubMed ID: 26426540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of meropenem in critically ill patients with severe infections.
    Binder L; Schwörer H; Hoppe S; Streit F; Neumann S; Beckmann A; Wachter R; Oellerich M; Walson PD
    Ther Drug Monit; 2013 Feb; 35(1):63-70. PubMed ID: 23318279
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic drug monitoring of antibiotic agents: evaluation of predictive performance.
    Šíma M; Bakhouche H; Hartinger J; Cikánková T; Slanař O
    Eur J Hosp Pharm; 2019 Mar; 26(2):85-88. PubMed ID: 31157105
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy.
    Economou CJP; Wong G; McWhinney B; Ungerer JPJ; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2017 May; 49(5):589-594. PubMed ID: 28341612
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Performance of a dosage individualization table for extended interval gentamicin in neonates beyond the first week of life.
    Dersch-Mills D; Akierman A; Alshaikh B; Sundaram A; Yusuf K
    J Matern Fetal Neonatal Med; 2016; 29(9):1451-6. PubMed ID: 26043646
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Research of optimal dosing regimens and therapeutic drug monitoring for vancomycin by clinical pharmacists: analysis of 7-year data].
    Xu G; Chen E; Mao E; Che Z; He J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):640-645. PubMed ID: 30045790
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Therapeutic monitoring of amikacin and gentamicin in routine clinical practice].
    Kacířová I; Grundmann M
    Vnitr Lek; 2015 Jan; 61(1):33-41. PubMed ID: 25693614
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of an Extended Interval Fondaparinux Dosing Regimen for Venous Thromboembolism Prophylaxis in Critically Ill Patients with Severe Renal Dysfunction Using Antifactor Xa Levels.
    Wahby KA; Riley LK; Tennenberg SD
    Pharmacotherapy; 2017 Oct; 37(10):1241-1248. PubMed ID: 28833353
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Validation of a dosage individualization table for extended-interval gentamicin in neonates.
    Dersch-Mills D; Akierman A; Alshaikh B; Yusuf K
    Ann Pharmacother; 2012; 46(7-8):935-42. PubMed ID: 22739714
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between hemodynamic and vital support measures and pharmacokinetic variability of amikacin in critically ill patients with sepsis.
    Lugo G; Castañeda-Hernández G
    Crit Care Med; 1997 May; 25(5):806-11. PubMed ID: 9187600
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of Renal Replacement Modalities on Amikacin Population Pharmacokinetics in Critically Ill Patients on Continuous Renal Replacement Therapy.
    Roger C; Wallis SC; Muller L; Saissi G; Lipman J; Lefrant JY; Roberts JA
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4901-9. PubMed ID: 27270279
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Usage Pattern and Serum Level Measurement of Amikacin in the Internal Medicine Ward of the Largest Referral Hospital in the South of Iran: A Pharmacoepidemiological Study.
    Namazi S; Sagheb MM; Hashempour MM; Sadatsharifi A
    Iran J Med Sci; 2016 May; 41(3):191-9. PubMed ID: 27217603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amikacin in Critically Ill Patients: A Review of Population Pharmacokinetic Studies.
    Marsot A; Guilhaumou R; Riff C; Blin O
    Clin Pharmacokinet; 2017 Feb; 56(2):127-138. PubMed ID: 27324191
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative nephrotoxicity and tissue accumulation of dactimicin, amikacin and gentamicin.
    Bonadio M; Maccanti O; Giovannini L; Bertelli AA; Scalori V; Alessandrì MG; Bertelli A
    Drugs Exp Clin Res; 1987; 13(12):747-50. PubMed ID: 3447878
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of Amikacin Pharmacokinetics in Critically Ill Patients with Intra-abdominal Sepsis.
    Shahrami B; Najmeddin F; Rouini MR; Najafi A; Sadeghi K; Amini S; Khezrnia SS; Sharifnia HR; Mojtahedzadeh M
    Adv Pharm Bull; 2020 Jan; 10(1):114-118. PubMed ID: 32002369
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.